HT
FOLD

HAP Trading’s Amicus Therapeutics FOLD Stock Holding History

HAP Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,527
Closed -$296K – 2641
2021
Q3 		$253K Buy
+26,527
New +$271K 0.01% 943
2021
Q2 		– Sell
-59,224
Closed -$578K – 2471
2021
Q1 		$585K Buy
59,224
+8,156
+16% +$126K 0.03% 442
2020
Q4 		$1.18M Buy
+51,068
New +$1.04M 0.03% 379
2017
Q3 		– Sell
-90,195
Closed -$1.19M – 943
2017
Q2 		$908K Buy
90,195
+31,886
+55% +$257K 0.05% 271
2017
Q1 		$416K Buy
+58,309
New +$369K 0.03% 362

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

HAP Trading's FOLD Position: Q4 2021 in Review

HAP Trading sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 26,527 shares — an estimated $296K sold.

HAP Trading first reported a position in FOLD in Q1 2017 and held it in 5 quarters. The position peaked at $1.18M in Q4 2020. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.

  • HAP Trading reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 26,527 Amicus Therapeutics shares in Q4 2021, an estimated $296K.
  • HAP Trading first reported a position in Amicus Therapeutics in Q1 2017 and held it in 5 quarters.
  • HAP Trading's Amicus Therapeutics position peaked at $1.18M in Q4 2020.
  • 224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.